Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 209 articles:
HTML format
Text format



Single Articles


    January 2017
  1. YANG SC, Hsu CN, Liang CM, Tai WC, et al
    Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.
    PLoS One. 2017;12:e0168918.
    PubMed     Text format     Abstract available


  2. DEGRE D, Serste T, Lasser L, Delwaide J, et al
    Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium.
    PLoS One. 2017;12:e0170933.
    PubMed     Text format     Abstract available


  3. GIMENEZ-GARZO C, Garces JJ, Urios A, Mangas-Losada A, et al
    The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients.
    PLoS One. 2017;12:e0171211.
    PubMed     Text format     Abstract available


  4. TRAYKOVA D, Schneider B, Chojkier M, Buck M, et al
    Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients.
    PLoS One. 2017;12:e0169310.
    PubMed     Text format     Abstract available


  5. HOLLENBACH M, Thonig A, Pohl S, Ripoll C, et al
    Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis.
    PLoS One. 2017;12:e0171260.
    PubMed     Text format     Abstract available


  6. BECKER S, Kinny-Koster B, Bartels M, Scholz M, et al
    Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
    PLoS One. 2017;12:e0174424.
    PubMed     Text format     Abstract available


  7. WANG YC, Chou CT, Lin CP, Chen YL, et al
    The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    PLoS One. 2017;12:e0174594.
    PubMed     Text format     Abstract available


  8. GAO B, Zhang X, Huang Y, Yang Z, et al
    Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.
    PLoS One. 2017;12:e0174142.
    PubMed     Text format     Abstract available


  9. YE Q, Yin W, Zhang L, Xiao H, et al
    The value of grip test, lysophosphatidlycholines, glycerophosphocholine, ornithine, glucuronic acid decrement in assessment of nutritional and metabolic characteristics in hepatitis B cirrhosis.
    PLoS One. 2017;12:e0175165.
    PubMed     Text format     Abstract available


  10. IBUSUKI R, Uto H, Oda K, Ohshige A, et al
    Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis.
    PLoS One. 2017;12:e0174913.
    PubMed     Text format     Abstract available


  11. KREMERS RMW, Kleinegris MC, Ninivaggi M, de Laat B, et al
    Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis.
    PLoS One. 2017;12:e0177020.
    PubMed     Text format     Abstract available


  12. YOON K, Jeong WK, Kim Y, Kim MY, et al
    2-dimensional shear wave elastography: Interobserver agreement and factors related to interobserver discrepancy.
    PLoS One. 2017;12:e0175747.
    PubMed     Text format     Abstract available


  13. MCPHERSON S, Wilkinson N, Tiniakos D, Wilkinson J, et al
    A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0175717.
    PubMed     Text format     Abstract available


  14. LI Z, Lin B, Lin G, Wu Y, et al
    Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
    PLoS One. 2017;12:e0178580.
    PubMed     Text format     Abstract available


  15. CHIU NC, Su CW, Liu CA, Huang YH, et al
    Interval to vascularization development in cirrhotic precursor nodules in patients with hepatitis B and C virus co-infections.
    PLoS One. 2017;12:e0178841.
    PubMed     Text format     Abstract available


  16. HAN EC, Ryoo SB, Park JW, Yi JW, et al
    Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.
    PLoS One. 2017;12:e0178920.
    PubMed     Text format     Abstract available


  17. CHANG CC, Lee WS, Hsieh HG, Chuang CL, et al
    Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats.
    PLoS One. 2017;12:e0179809.
    PubMed     Text format     Abstract available


  18. HUNG TH, Liang CM, Hsu CN, Tai WC, et al
    Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.
    PLoS One. 2017;12:e0181858.
    PubMed     Text format     Abstract available


  19. WU CK, Liang CM, Hsu CN, Hung TH, et al
    The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation.
    PLoS One. 2017;12:e0169884.
    PubMed     Text format     Abstract available


  20. ZHAO J, Zhai F, Cheng J, He Q, et al
    Evaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography.
    PLoS One. 2017;12:e0170073.
    PubMed     Text format     Abstract available


  21. DONAIRES FS, Scatena NF, Alves-Paiva RM, Podlevsky JD, et al
    Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0183287.
    PubMed     Text format     Abstract available


  22. LIU X, He L, Han J, Wang L, et al
    Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.
    PLoS One. 2017;12:e0170605.
    PubMed     Text format     Abstract available


  23. ZHANG BB, Yan C, Fang F, Du Y, et al
    Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis.
    PLoS One. 2017;12:e0171005.
    PubMed     Text format     Abstract available


  24. SALDANA RS, Schrem H, Barthold M, Kaltenborn A, et al
    Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.
    PLoS One. 2017;12:e0170499.
    PubMed     Text format     Abstract available


  25. WANG L, Feng Y, Ma X, Wang G, et al
    Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.
    PLoS One. 2017;12:e0182969.
    PubMed     Text format     Abstract available


  26. LE MH, Devaki P, Ha NB, Jun DW, et al
    Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
    PLoS One. 2017;12:e0173499.
    PubMed     Text format     Abstract available


  27. GARDINALI NR, Guimaraes JR, Melgaco JG, Kevorkian YB, et al
    Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy.
    PLoS One. 2017;12:e0174070.
    PubMed     Text format     Abstract available


  28. STAHMEYER JT, Rossol S, Liersch S, Guerra I, et al
    Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany.
    PLoS One. 2017;12:e0169401.
    PubMed     Text format     Abstract available


  29. KJAERGAARD M, Thiele M, Jansen C, Staehr Madsen B, et al
    High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal.
    PLoS One. 2017;12:e0173992.
    PubMed     Text format     Abstract available


  30. KOMIYAMA Y, Kurosaki M, Nakanishi H, Takahashi Y, et al
    Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.
    PLoS One. 2017;12:e0174649.
    PubMed     Text format     Abstract available


  31. DIJKSTRA H, Wolff D, van Melle JP, Bartelds B, et al
    Diminished liver microperfusion in Fontan patients: A biexponential DWI study.
    PLoS One. 2017;12:e0173149.
    PubMed     Text format     Abstract available


  32. LEE SM, Lee JM, Kang HJ, Yang HK, et al
    Liver fibrosis staging with a new 2D-shear wave elastography using comb-push technique: Applicability, reproducibility, and diagnostic performance.
    PLoS One. 2017;12:e0177264.
    PubMed     Text format     Abstract available


  33. ROKUSZ A, Veres D, Szucs A, Bugyik E, et al
    Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.
    PLoS One. 2017;12:e0176518.
    PubMed     Text format     Abstract available


  34. YANG KL, Chang WT, Hong MY, Hung KC, et al
    Prevention of TGF-beta-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation.
    PLoS One. 2017;12:e0174008.
    PubMed     Text format     Abstract available


  35. KRAWCZYK M, Zimmermann S, Hess G, Holz R, et al
    Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.
    PLoS One. 2017;12:e0173506.
    PubMed     Text format     Abstract available


  36. SONG YN, Dong S, Wei B, Liu P, et al
    Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data.
    PLoS One. 2017;12:e0173598.
    PubMed     Text format     Abstract available


  37. KONDILI LA, Gaeta GB, Ieluzzi D, Zignego AL, et al
    Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
    PLoS One. 2017;12:e0172159.
    PubMed     Text format     Abstract available


  38. JOLY P, Vignaud H, Di Martino J, Ruiz M, et al
    ERAD defects and the HFE-H63D variant are associated with increased risk of liver damages in Alpha 1-Antitrypsin Deficiency.
    PLoS One. 2017;12:e0179369.
    PubMed     Text format     Abstract available


  39. NAKAMURA M, Kanda T, Jiang X, Haga Y, et al
    Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis.
    PLoS One. 2017;12:e0177302.
    PubMed     Text format     Abstract available


  40. LAI LL, Chan WK, Sthaneshwar P, Nik Mustapha NR, et al
    Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0174982.
    PubMed     Text format     Abstract available


  41. DOLD L, Luda C, Schwarze-Zander C, Boesecke C, et al
    Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).
    PLoS One. 2017;12:e0178685.
    PubMed     Text format     Abstract available


  42. KRAUSKOPF J, de Kok TM, Schomaker SJ, Gosink M, et al
    Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.
    PLoS One. 2017;12:e0177928.
    PubMed     Text format     Abstract available


  43. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Text format     Abstract available


  44. MOQUEET N, Kanagaratham C, Gill MJ, Hull M, et al
    A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.
    PLoS One. 2017;12:e0176282.
    PubMed     Text format     Abstract available


  45. WONG MW, Chen MJ, Chen HL, Kuo YC, et al
    Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligation.
    PLoS One. 2017;12:e0182529.
    PubMed     Text format     Abstract available


  46. KIM G, Kim KJ, Rhee Y, Lim SK, et al
    Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0182202.
    PubMed     Text format     Abstract available


  47. CAI G, Chen B, Li Z, Wei W, et al
    The different expressed serum proteins in rhCygb treated rat model of liver fibrosis by the optimized two-dimensional gel electrophoresis.
    PLoS One. 2017;12:e0177968.
    PubMed     Text format     Abstract available


  48. GUPTA N, Kabahizi J, Mukabatsinda C, Walker TD, et al
    "Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.
    PLoS One. 2017;12:e0174148.
    PubMed     Text format     Abstract available


  49. CHANG JY, Kim SE, Kim TH, Woo SY, et al
    Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients.
    PLoS One. 2017;12:e0186120.
    PubMed     Text format     Abstract available


  50. LEVENTER-ROBERTS M, Hammerman A, Brufman I, Hoshen M, et al
    Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study.
    PLoS One. 2017;12:e0176858.
    PubMed     Text format     Abstract available


  51. PRESTIGIACOMO V, Weston A, Messner S, Lampart F, et al
    Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis.
    PLoS One. 2017;12:e0179995.
    PubMed     Text format     Abstract available


  52. LE CORVEC M, Jezequel C, Monbet V, Fatih N, et al
    Mid-infrared spectroscopy of serum, a promising non-invasive method to assess prognosis in patients with ascites and cirrhosis.
    PLoS One. 2017;12:e0185997.
    PubMed     Text format     Abstract available


  53. SAGNELLI C, Uberti-Foppa C, Hasson H, Bellini G, et al
    Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.
    PLoS One. 2017;12:e0181890.
    PubMed     Text format     Abstract available


    January 2016
  54. THOMSEN KL, Macnaughtan J, Tritto G, Mookerjee RP, et al
    Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy.
    PLoS One. 2016;11:e0146076.
    PubMed     Text format     Abstract available


  55. LI TH, Huang CC, Yang YY, Lee KC, et al
    Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats.
    PLoS One. 2016;11:e0147212.
    PubMed     Text format     Abstract available


  56. JIAO J, Watt GP, Lee M, Rahbar MH, et al
    Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity.
    PLoS One. 2016;11:e0150978.
    PubMed     Text format     Abstract available


  57. CHEN QF, Chen HJ, Liu J, Sun T, et al
    Machine Learning Classification of Cirrhotic Patients with and without Minimal Hepatic Encephalopathy Based on Regional Homogeneity of Intrinsic Brain Activity.
    PLoS One. 2016;11:e0151263.
    PubMed     Text format     Abstract available


  58. ROMAN E, Garcia-Galceran C, Torrades T, Herrera S, et al
    Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial.
    PLoS One. 2016;11:e0151652.
    PubMed     Text format     Abstract available


  59. ESTRELA HF, Damasio ES, Fonseca EK, Bergamaschi CT, et al
    Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats.
    PLoS One. 2016;11:e0152512.
    PubMed     Text format     Abstract available


  60. ARAUJO OC, Rosa AS, Fernandes A, Niel C, et al
    RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
    PLoS One. 2016;11:e0153796.
    PubMed     Text format     Abstract available


  61. WANG D, Chen TW, Zhang XM, Li J, et al
    Liver Lobe Based Multi-Echo Gradient Recalled Echo T2*-Weighted Imaging in Chronic Hepatitis B-Related Cirrhosis: Association with the Presence and Child-Pugh Class of Cirrhosis.
    PLoS One. 2016;11:e0154545.
    PubMed     Text format     Abstract available


  62. TISCHENDORF M, Miesbach W, Chattah U, Chattah Z, et al
    Differential Kinetics of Coagulation Factors and Natural Anticoagulants in Patients with Liver Cirrhosis: Potential Clinical Implications.
    PLoS One. 2016;11:e0155337.
    PubMed     Text format     Abstract available


  63. VESPASIANI-GENTILUCCI U, Gallo P, Piemonte F, Riva E, et al
    Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology.
    PLoS One. 2016;11:e0156113.
    PubMed     Text format     Abstract available


  64. D'AMBROSIO R, Degasperi E, Aghemo A, Fraquelli M, et al
    Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.
    PLoS One. 2016;11:e0155967.
    PubMed     Text format     Abstract available


  65. LAHMER T, Brandl A, Rasch S, Schmid RM, et al
    Fungal Peritonitis: Underestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis.
    PLoS One. 2016;11:e0158389.
    PubMed     Text format     Abstract available


  66. SANSOE G, Aragno M, Mastrocola R, Mengozzi G, et al
    Alpha-2A Adrenoceptor Agonist Guanfacine Restores Diuretic Efficiency in Experimental Cirrhotic Ascites: Comparison with Clonidine.
    PLoS One. 2016;11:e0158486.
    PubMed     Text format     Abstract available


  67. GRAUPERA I, Sola E, Fabrellas N, Moreira R, et al
    Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
    PLoS One. 2016;11:e0157371.
    PubMed     Text format     Abstract available


  68. ZHANG B, Liang L, Dong Y, Lian Z, et al
    Intravoxel Incoherent Motion MR Imaging for Staging of Hepatic Fibrosis.
    PLoS One. 2016;11:e0147789.
    PubMed     Text format     Abstract available


  69. LYTLE KA, Jump DB
    Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    PLoS One. 2016;11:e0146942.
    PubMed     Text format     Abstract available


  70. PEREPELYUK M, Chin L, Cao X, van Oosten A, et al
    Normal and Fibrotic Rat Livers Demonstrate Shear Strain Softening and Compression Stiffening: A Model for Soft Tissue Mechanics.
    PLoS One. 2016;11:e0146588.
    PubMed     Text format     Abstract available


  71. KUMAR S, Wang J, Rani R, Gandhi CR, et al
    Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice.
    PLoS One. 2016;11:e0147864.
    PubMed     Text format     Abstract available


  72. PIRHONEN J, Arola J, Sadevirta S, Luukkonen P, et al
    Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study.
    PLoS One. 2016;11:e0147804.
    PubMed     Text format     Abstract available


  73. FUJIMOTO Y, Urashima T, Shimura D, Ito R, et al
    Low Cardiac Output Leads Hepatic Fibrosis in Right Heart Failure Model Rats.
    PLoS One. 2016;11:e0148666.
    PubMed     Text format     Abstract available


  74. ALDAMIZ-ECHEVARRIA T, Berenguer J, Miralles P, Jimenez-Sousa MA, et al
    Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome.
    PLoS One. 2016;11:e0148537.
    PubMed     Text format     Abstract available


  75. TAPPER EB, Hunink MG, Afdhal NH, Lai M, et al
    Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
    PLoS One. 2016;11:e0147237.
    PubMed     Text format     Abstract available


  76. HAMETNER S, Ferlitsch A, Ferlitsch M, Etschmaier A, et al
    The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.
    PLoS One. 2016;11:e0149230.
    PubMed     Text format     Abstract available


  77. ARAUJO JUNIOR RF, Garcia VB, Leitao RF, Brito GA, et al
    Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells.
    PLoS One. 2016;11:e0148868.
    PubMed     Text format     Abstract available


  78. SOLOMON SS, Srikrishnan AK, McFall AM, Kumar MS, et al
    Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India.
    PLoS One. 2016;11:e0147879.
    PubMed     Text format     Abstract available


  79. ALT Y, Grimm A, Schlegel L, Grambihler A, et al
    The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease.
    PLoS One. 2016;11:e0151200.
    PubMed     Text format     Abstract available


  80. JANG ES, Jeong SH, Kim JW, Choi YS, et al
    Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0151069.
    PubMed     Text format     Abstract available


  81. SIEGMUND SV, Schlosser M, Schildberg FA, Seki E, et al
    Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells.
    PLoS One. 2016;11:e0150893.
    PubMed     Text format     Abstract available


  82. TANDON P, James MT, Abraldes JG, Karvellas CJ, et al
    Relevance of New Definitions to Incidence and Prognosis of Acute Kidney Injury in Hospitalized Patients with Cirrhosis: A Retrospective Population-Based Cohort Study.
    PLoS One. 2016;11:e0160394.
    PubMed     Text format     Abstract available


  83. CHOW LN, Schreiner P, Ng BY, Lo B, et al
    Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice.
    PLoS One. 2016;11:e0151765.
    PubMed     Text format     Abstract available


  84. BAIOCCHINI A, Montaldo C, Conigliaro A, Grimaldi A, et al
    Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution.
    PLoS One. 2016;11:e0151736.
    PubMed     Text format     Abstract available


  85. TAWARA S, Tatsumi T, Iio S, Kobayashi I, et al
    Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
    PLoS One. 2016;11:e0151828.
    PubMed     Text format     Abstract available


  86. ZHANG Z, Wang G, Kang K, Wu G, et al
    The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection.
    PLoS One. 2016;11:e0152757.
    PubMed     Text format     Abstract available


  87. RACHAKONDA V, Borhani AA, Dunn MA, Andrzejewski M, et al
    Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis.
    PLoS One. 2016;11:e0159142.
    PubMed     Text format     Abstract available


  88. MONTALBANO M, Curcuru G, Shirafkan A, Vento R, et al
    Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion.
    PLoS One. 2016;11:e0153613.
    PubMed     Text format     Abstract available


  89. JI J, Wang H, Li Y, Zheng L, et al
    Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus alpha-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    PLoS One. 2016;11:e0153227.
    PubMed     Text format     Abstract available


  90. KLEIN S, Hinuber C, Hittatiya K, Schierwagen R, et al
    Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension.
    PLoS One. 2016;11:e0162144.
    PubMed     Text format     Abstract available


  91. SANSOE G, Aragno M, Mastrocola R, Mengozzi G, et al
    Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data.
    PLoS One. 2016;11:e0162644.
    PubMed     Text format     Abstract available


  92. HUNG TH, Lay CJ, Tseng CW, Tsai CC, et al
    The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study.
    PLoS One. 2016;11:e0162987.
    PubMed     Text format     Abstract available


  93. SOBREVALS L, Enguita M, Quiroga J, Prieto J, et al
    Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats.
    PLoS One. 2016;11:e0162955.
    PubMed     Text format     Abstract available


  94. YE Q, Qian BX, Yin WL, Wang FM, et al
    Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls.
    PLoS One. 2016;11:e0163423.
    PubMed     Text format     Abstract available


  95. LIU TL, Barritt Iv AS, Weinberger M, Paul JE, et al
    Who Treats Patients with Diabetes and Compensated Cirrhosis.
    PLoS One. 2016;11:e0165574.
    PubMed     Text format     Abstract available


  96. FJELD K, Beer S, Johnstone M, Zimmer C, et al
    Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis.
    PLoS One. 2016;11:e0165567.
    PubMed     Text format     Abstract available


  97. FAN WC, Liu CW, Ou SM, Huang CC, et al
    TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients.
    PLoS One. 2016;11:e0166458.
    PubMed     Text format     Abstract available


  98. DELEURAN T, Vilstrup H, Overgaard S, Jepsen P, et al
    No Increased Risk for Primary Osteoarthritis in Liver Cirrhosis - A Danish Nationwide Cohort Study.
    PLoS One. 2016;11:e0167134.
    PubMed     Text format     Abstract available


  99. JEON I, Cho ES, Kim JH, Kim DJ, et al
    Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30 degrees Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis.
    PLoS One. 2016;11:e0167701.
    PubMed     Text format     Abstract available


  100. NUNEZ-TORRES R, Macias J, Mancebo M, Frias M, et al
    The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
    PLoS One. 2016;11:e0168265.
    PubMed     Text format     Abstract available


  101. TUTTOLOMONDO A, Di Raimondo D, Bellia C, Clemente G, et al
    Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.
    PLoS One. 2016;11:e0165443.
    PubMed     Text format     Abstract available


  102. SARRAZIN C, Manns M, Calleja JL, Garcia-Samaniego J, et al
    HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment.
    PLoS One. 2016;11:e0168544.
    PubMed     Text format     Abstract available


  103. NOVO-VELEIRO I, Cieza-Borrella C, Pastor I, Chamorro AJ, et al
    A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men.
    PLoS One. 2016;11:e0168685.
    PubMed     Text format     Abstract available


  104. GAO Y, Ren H, Meng F, Li J, et al
    Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
    PLoS One. 2016;11:e0154419.
    PubMed     Text format     Abstract available


  105. YASUI Y, Abe T, Kurosaki M, Higuchi M, et al
    Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0154558.
    PubMed     Text format     Abstract available


  106. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis.
    PLoS One. 2016;11:e0164224.
    PubMed     Text format     Abstract available


  107. ZHENG S, Zhang P, Chen Y, Zheng S, et al
    Inhibition of Notch Signaling Attenuates Schistosomiasis Hepatic Fibrosis via Blocking Macrophage M2 Polarization.
    PLoS One. 2016;11:e0166808.
    PubMed     Text format     Abstract available


  108. AIKEN T, Garber A, Thomas D, Hamon N, et al
    Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
    PLoS One. 2016;11:e0166998.
    PubMed     Text format     Abstract available


  109. PUIGVEHI M, Hernandez J, Broquetas T, Coll S, et al
    Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF(R)) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years.
    PLoS One. 2016;11:e0164883.
    PubMed     Text format     Abstract available


  110. BURKE SCHINKEL SC, Carrasco-Medina L, Cooper CL, Crawley AM, et al
    Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection.
    PLoS One. 2016;11:e0157055.
    PubMed     Text format     Abstract available


  111. NGUYEN TRUONG T, Laureillard D, Lacombe K, Duong Thi H, et al
    High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
    PLoS One. 2016;11:e0153744.
    PubMed     Text format     Abstract available


  112. IBRAHIM MK, Salum GM, Bader El Din NG, Dawood RM, et al
    Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.
    PLoS One. 2016;11:e0154512.
    PubMed     Text format     Abstract available


  113. SHI L, Qin E, Zhou J, Zhao J, et al
    HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells.
    PLoS One. 2016;11:e0158386.
    PubMed     Text format     Abstract available


  114. JURADO-GARCIA J, Munoz Garcia-Borruel M, Rodriguez-Peralvarez ML, Ruiz-Cuesta P, et al
    Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality.
    PLoS One. 2016;11:e0155822.
    PubMed     Text format     Abstract available


  115. AMORAS EDA S, Gomes ST, Freitas FB, Santana BB, et al
    Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection.
    PLoS One. 2016;11:e0156604.
    PubMed     Text format     Abstract available


  116. ZHANG YH, Zhao Y, Rajapaksa US, Lawrence TM, et al
    A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort.
    PLoS One. 2016;11:e0158037.
    PubMed     Text format     Abstract available


  117. LIN MV, Sise ME, Pavlakis M, Amundsen BM, et al
    Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
    PLoS One. 2016;11:e0158431.
    PubMed     Text format     Abstract available


  118. EMBADE N, Marino Z, Diercks T, Cano A, et al
    Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy.
    PLoS One. 2016;11:e0155094.
    PubMed     Text format     Abstract available


  119. CHEKURI S, Nickerson J, Bichoupan K, Sefcik R, et al
    Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus.
    PLoS One. 2016;11:e0159413.
    PubMed     Text format     Abstract available


  120. PELUSI S, Petta S, Rosso C, Borroni V, et al
    Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0163069.
    PubMed     Text format     Abstract available


    January 2015
  121. LIN WC, Hsu TW, Chen CL, Lu CH, et al
    Resting State-fMRI with ReHo Analysis as a Non-Invasive Modality for the Prognosis of Cirrhotic Patients with Overt Hepatic Encephalopathy.
    PLoS One. 2015;10:e0126834.
    PubMed     Text format     Abstract available


  122. LIU X, Chi X, Gong Q, Gao L, et al
    Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    PLoS One. 2015;10:e0127518.
    PubMed     Text format     Abstract available


  123. MERLI M, Lucidi C, Di Gregorio V, Falcone M, et al
    The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
    PLoS One. 2015;10:e0127448.
    PubMed     Text format     Abstract available


  124. ARIZA X, Sola E, Elia C, Barreto R, et al
    Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis.
    PLoS One. 2015;10:e0128145.
    PubMed     Text format     Abstract available


  125. CHEN J, Zhang X, Xu Y, Li X, et al
    Hepatic Progenitor Cells Contribute to the Progression of 2-Acetylaminofluorene/Carbon Tetrachloride-Induced Cirrhosis via the Non-Canonical Wnt Pathway.
    PLoS One. 2015;10:e0130310.
    PubMed     Text format     Abstract available


  126. KIMURA T, Takahashi S, Takahashi I, Nishibuchi I, et al
    The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0125231.
    PubMed     Text format     Abstract available


  127. SEKIGUCHI T, Umemura T, Fujimori N, Shibata S, et al
    Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis.
    PLoS One. 2015;10:e0131658.
    PubMed     Text format     Abstract available


  128. MEIKLE PJ, Mundra PA, Wong G, Rahman K, et al
    Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment.
    PLoS One. 2015;10:e0130346.
    PubMed     Text format     Abstract available


  129. FINKELMEIER F, Kronenberger B, Zeuzem S, Piiper A, et al
    Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis.
    PLoS One. 2015;10:e0132119.
    PubMed     Text format     Abstract available


  130. LI R, Tang CL, Zhang Y, Ma KS, et al
    Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound-A Prospective Study in Non-Cirrhotic Patients.
    PLoS One. 2015;10:e0132290.
    PubMed     Text format     Abstract available


  131. CHO EJ, Kim MY, Lee JH, Lee IY, et al
    Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis.
    PLoS One. 2015;10:e0133935.
    PubMed     Text format     Abstract available


  132. SANCHEZ-ANTOLIN G, Almohalla-Alvarez C, Bueno P, Almansa R, et al
    Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis.
    PLoS One. 2015;10:e0137128.
    PubMed     Text format     Abstract available


  133. GRAMMATIKOS G, Ferreiros N, Waidmann O, Bon D, et al
    Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis.
    PLoS One. 2015;10:e0138130.
    PubMed     Text format     Abstract available


  134. KERBERT AJ, Verbeke L, Chiang FW, Laleman W, et al
    Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.
    PLoS One. 2015;10:e0138264.
    PubMed     Text format     Abstract available


  135. LEPIDA A, Colombo M, Fernandez I, Abdurakhmanov D, et al
    Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis.
    PLoS One. 2015;10:e0138503.
    PubMed     Text format     Abstract available


  136. KLEIN S, Herath CB, Schierwagen R, Grace J, et al
    Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis.
    PLoS One. 2015;10:e0138732.
    PubMed     Text format     Abstract available


  137. FORNARI F, Ferracin M, Trere D, Milazzo M, et al
    Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
    PLoS One. 2015;10:e0141448.
    PubMed     Text format     Abstract available


  138. LIU F, Wang X, Wu G, Chen L, et al
    Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis.
    PLoS One. 2015;10:e0142457.
    PubMed     Text format     Abstract available


  139. LI RK, Palmer SL, Zeng MS, Qiang JW, et al
    Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.
    PLoS One. 2015;10:e0142882.
    PubMed     Text format     Abstract available


  140. ABOUT F, Oudot-Mellakh T, Niay J, Rabiega P, et al
    Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.
    PLoS One. 2015;10:e0145105.
    PubMed     Text format     Abstract available


  141. MATSUE Y, Tsutsumi M, Hayashi N, Saito T, et al
    Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.
    PLoS One. 2015;10:e0118744.
    PubMed     Text format     Abstract available


  142. LIU Y, Huang L, Lu Y, Xi XE, et al
    Relationships between the Osteocalcin Gene Polymorphisms, Serum Osteocalcin Levels, and Hepatitis B Virus-Related Hepatocellular Carcinoma in a Chinese Population.
    PLoS One. 2015;10:e0116479.
    PubMed     Text format     Abstract available


  143. HOFFMANN CJ, Hoffmann JD, Kensler C, van der Watt M, et al
    Tuberculosis and Hepatic Steatosis Are Prevalent Liver Pathology Findings among HIV-Infected Patients in South Africa.
    PLoS One. 2015;10:e0117813.
    PubMed     Text format     Abstract available


  144. LIN YY, Shiau S, Fang CT
    Risk Factors for Invasive Cryptococcus neoformans Diseases: A Case-Control Study.
    PLoS One. 2015;10:e0119090.
    PubMed     Text format     Abstract available


  145. JIA Y, Zeng Z, Li Y, Li Z, et al
    Impaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression.
    PLoS One. 2015;10:e0117458.
    PubMed     Text format     Abstract available


  146. JANSEN C, Reiberger T, Huang J, Eischeid H, et al
    Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection.
    PLoS One. 2015;10:e0116768.
    PubMed     Text format     Abstract available


  147. DECARIS ML, Emson CL, Li K, Gatmaitan M, et al
    Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
    PLoS One. 2015;10:e0123311.
    PubMed     Text format     Abstract available


  148. TAN Y, Ye Y, Zhou X, Chen L, et al
    Age as a Predictor of Significant Fibrosis Features in HBeAg-Negative Chronic Hepatitis B Virus Infection with Persistently Normal Alanine Aminotransferase.
    PLoS One. 2015;10:e0123452.
    PubMed     Text format     Abstract available


  149. HOCHST B, Mikulec J, Baccega T, Metzger C, et al
    Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis.
    PLoS One. 2015;10:e0119662.
    PubMed     Text format     Abstract available


  150. PARENTE DB, Paiva FF, Oliveira Neto JA, Machado-Silva L, et al
    Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients.
    PLoS One. 2015;10:e0125653.
    PubMed     Text format     Abstract available


  151. KNABEL MK, Ramachandran K, Karhadkar S, Hwang HW, et al
    Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.
    PLoS One. 2015;10:e0124411.
    PubMed     Text format     Abstract available


  152. ZHANG Q, Li Y, Han T, Nie C, et al
    Comparison of current diagnostic criteria for acute-on-chronic liver failure.
    PLoS One. 2015;10:e0122158.
    PubMed     Text format     Abstract available


  153. LIANG T, Alloosh M, Bell LN, Fullenkamp A, et al
    Liver injury and fibrosis induced by dietary challenge in the Ossabaw miniature Swine.
    PLoS One. 2015;10:e0124173.
    PubMed     Text format     Abstract available


  154. KONUMA K, Itoh M, Suganami T, Kanai S, et al
    Eicosapentaenoic Acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice.
    PLoS One. 2015;10:e0121528.
    PubMed     Text format     Abstract available


  155. AMORAS EDA S, Gomes ST, Freitas FB, Santana BB, et al
    NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes.
    PLoS One. 2015;10:e0121754.
    PubMed     Text format     Abstract available


  156. SCOTT C, Cha K, Rao R, Liddle C, et al
    Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injury.
    PLoS One. 2015;10:e0121650.
    PubMed     Text format     Abstract available


  157. TACHTATZIS PM, Marshall A, Aravinthan A, Verma S, et al
    Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.
    PLoS One. 2015;10:e0127511.
    PubMed     Text format     Abstract available


  158. MULLHAUPT B, Bruggmann P, Bihl F, Blach S, et al
    Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland.
    PLoS One. 2015;10:e0125214.
    PubMed     Text format     Abstract available


  159. LIU H, Fu J, Hong R, Liu L, et al
    Acoustic Radiation Force Impulse Elastography for the Non-Invasive Evaluation of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review & Meta-Analysis.
    PLoS One. 2015;10:e0127782.
    PubMed     Text format     Abstract available


  160. DOMAGALSKI K, Pawlowska M, Kozielewicz D, Dybowska D, et al
    The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.
    PLoS One. 2015;10:e0130899.
    PubMed     Text format     Abstract available


  161. ROLLET-KURHAJEC KC, Moodie EE, Walmsley S, Cooper C, et al
    Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection - The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
    PLoS One. 2015;10:e0129868.
    PubMed     Text format     Abstract available


  162. YE L, Yu H, Li C, Hirsch ML, et al
    Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice.
    PLoS One. 2015;10:e0130052.
    PubMed     Text format     Abstract available


  163. KASUMOV T, Li L, Li M, Gulshan K, et al
    Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.
    PLoS One. 2015;10:e0126910.
    PubMed     Text format     Abstract available


  164. BRAUN DL, Rauch A, Aouri M, Durisch N, et al
    A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
    PLoS One. 2015;10:e0133028.
    PubMed     Text format     Abstract available


  165. TACHI Y, Hirai T, Toyoda H, Tada T, et al
    Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.
    PLoS One. 2015;10:e0133515.
    PubMed     Text format     Abstract available


  166. TSAI CF, Chu CJ, Huang YH, Wang YP, et al
    Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6.
    PLoS One. 2015;10:e0128437.
    PubMed     Text format     Abstract available


  167. BANSAL R, Frelin L, Brenndorfer ED, Storm G, et al
    Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo.
    PLoS One. 2015;10:e0128466.
    PubMed     Text format     Abstract available


  168. MARQUEZ M, Romero-Cores P, Montes-Oca M, Martin-Aspas A, et al
    Immune Activation Response in Chronic HIV-Infected Patients: Influence of Hepatitis C Virus Coinfection.
    PLoS One. 2015;10:e0119568.
    PubMed     Text format     Abstract available


  169. LONG X, Chen Q, Zhao J, Rafaels N, et al
    An IL-13 Promoter Polymorphism Associated with Liver Fibrosis in Patients with Schistosoma japonicum.
    PLoS One. 2015;10:e0135360.
    PubMed     Text format     Abstract available


  170. AOUDJEHANE L, Bisch G, Scatton O, Granier C, et al
    Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C.
    PLoS One. 2015;10:e0134141.
    PubMed     Text format     Abstract available


  171. TAMAKI N, Kurosaki M, Higuchi M, Takada H, et al
    Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens.
    PLoS One. 2015;10:e0137351.
    PubMed     Text format     Abstract available


  172. THANAPIROM K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, et al
    Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.
    PLoS One. 2015;10:e0137365.
    PubMed     Text format     Abstract available


  173. NIELSEN MJ, Kazankov K, Leeming DJ, Karsdal MA, et al
    Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients.
    PLoS One. 2015;10:e0137302.
    PubMed     Text format     Abstract available


  174. LIM EJ, Chin R, Nachbur U, Silke J, et al
    Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
    PLoS One. 2015;10:e0138522.
    PubMed     Text format     Abstract available


  175. ZHENG S, Lu Q, Xu Y, Wang X, et al
    GdCl3 Attenuates Schistosomiasis japonicum Egg-Induced Granulomatosis Accompanied by Decreased Macrophage Infiltration in Murine Liver.
    PLoS One. 2015;10:e0132222.
    PubMed     Text format     Abstract available


  176. WU WP, Chou CT, Chen RC, Lee CW, et al
    Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C.
    PLoS One. 2015;10:e0140068.
    PubMed     Text format     Abstract available


  177. CHEN SH, Peng CY, Lai HC, Chang IP, et al
    Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis C.
    PLoS One. 2015;10:e0140554.
    PubMed     Text format     Abstract available


  178. SCHMID P, Bregenzer A, Huber M, Rauch A, et al
    Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
    PLoS One. 2015;10:e0138838.
    PubMed     Text format     Abstract available


  179. MOTAWI TK, Shaker OG, El-Maraghy SA, Senousy MA, et al
    Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    PLoS One. 2015;10:e0137706.
    PubMed     Text format     Abstract available


  180. MUSSINI C, Lorenzini P, Puoti M, Lichtner M, et al
    Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
    PLoS One. 2015;10:e0140877.
    PubMed     Text format     Abstract available


  181. KUMAGAI K, Tabu K, Sasaki F, Takami Y, et al
    Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
    PLoS One. 2015;10:e0143413.
    PubMed     Text format     Abstract available


  182. ZHANG X, Zhai L, Rong C, Qin X, et al
    Association of Ghrelin Gene Polymorphisms and Serum Ghrelin Levels with the Risk of Hepatitis B Virus-Related Liver Diseases in a Chinese Population.
    PLoS One. 2015;10:e0143069.
    PubMed     Text format     Abstract available


  183. AHN JM, Sinn DH, Gwak GY, Paik YH, et al
    Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.
    PLoS One. 2015;10:e0144777.
    PubMed     Text format     Abstract available


  184. PETTA S, Marrone O, Torres D, Buttacavoli M, et al
    Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2015;10:e0142210.
    PubMed     Text format     Abstract available


  185. SCHEINER B, Mandorfer M, Schwabl P, Payer BA, et al
    The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
    PLoS One. 2015;10:e0143429.
    PubMed     Text format     Abstract available


  186. BERNSMEIER C, Weisskopf DM, Pflueger MO, Mosimann J, et al
    Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.
    PLoS One. 2015;10:e0143293.
    PubMed     Text format     Abstract available


  187. WADE AJ, Macdonald DM, Doyle JS, Gordon A, et al
    The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.
    PLoS One. 2015;10:e0142770.
    PubMed     Text format     Abstract available


  188. CHENG J, Hou J, Ding H, Chen G, et al
    Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B.
    PLoS One. 2015;10:e0144425.
    PubMed     Text format     Abstract available


    January 2014
  189. KORHAN P, Erdal E, Kandemis E, Cokakli M, et al
    Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.
    PLoS One. 2014;9:e105278.
    PubMed     Text format     Abstract available


  190. ZHANG Y, Li Y, Lin C, Ding J, et al
    Aberrant upregulation of 14-3-3sigma and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma.
    PLoS One. 2014;9:e107251.
    PubMed     Text format     Abstract available


  191. THIELE M, Gluud LL, Fialla AD, Dahl EK, et al
    Large variations in risk of hepatocellular carcinoma and mortality in treatment naive hepatitis B patients: systematic review with meta-analyses.
    PLoS One. 2014;9:e107177.
    PubMed     Text format     Abstract available


  192. BERGLIN L, Bergquist A, Johansson H, Glaumann H, et al
    In situ characterization of intrahepatic non-parenchymal cells in PSC reveals phenotypic patterns associated with disease severity.
    PLoS One. 2014;9:e105375.
    PubMed     Text format     Abstract available


  193. KUO YH, Lu SN, Chen CH, Chang KC, et al
    The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy.
    PLoS One. 2014;9:e93160.
    PubMed     Text format     Abstract available


  194. ZHANG Y, Mao R, Yan R, Cai D, et al
    Transcription of Hepatitis B Virus Covalently Closed Circular DNA Is Regulated by CpG Methylation during Chronic Infection.
    PLoS One. 2014;9:e110442.
    PubMed     Text format     Abstract available


  195. DE NICOLA S, Dongiovanni P, Aghemo A, Cheroni C, et al
    Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis C.
    PLoS One. 2014;9:e106022.
    PubMed     Text format     Abstract available


  196. MOSCA E, Alfieri R, Milanesi L
    Diffusion of Information throughout the Host Interactome Reveals Gene Expression Variations in Network Proximity to Target Proteins of Hepatitis C Virus.
    PLoS One. 2014;9:e113660.
    PubMed     Text format     Abstract available


  197. LUNDBO LF, Clausen LN, Weis N, Schonning K, et al
    Influence of Hepatitis C Virus and IL28B Genotypes on Liver Stiffness.
    PLoS One. 2014;9:e115882.
    PubMed     Text format     Abstract available


  198. LI Y, Chen Y, Zhao Y
    The Diagnostic Value of the FIB-4 Index for Staging Hepatitis B-Related Fibrosis: A Meta-Analysis.
    PLoS One. 2014;9:e105728.
    PubMed     Text format     Abstract available


  199. LIU M, Wu Q, Chen P, Buchele B, et al
    A Boswellic Acid-Containing Extract Ameliorates Schistosomiasis Liver Granuloma and Fibrosis through Regulating NF-kappaB Signaling in Mice.
    PLoS One. 2014;9:e100129.
    PubMed     Text format     Abstract available


  200. YEHIA BR, Schranz AJ, Umscheid CA, Lo Re V 3rd, et al
    The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.
    PLoS One. 2014;9:e101554.
    PubMed     Text format     Abstract available


  201. KIM MS, Kim S, Myung H
    Degradation of AIMP1/p43 Induced by Hepatitis C Virus E2 Leads to Upregulation of TGF-beta Signaling and Increase in Surface Expression of gp96.
    PLoS One. 2014;9:e96302.
    PubMed     Text format     Abstract available


  202. TSENG CW, Chen CY, Chang TT, Tzeng SJ, et al
    Peginterferon alfa-2a is associated with elevations in alanine aminotransferase at the end of treatment in chronic hepatitis C patients with sustained virologic response.
    PLoS One. 2014;9:e100207.
    PubMed     Text format     Abstract available


  203. JANSEN C, Leeming DJ, Mandorfer M, Byrjalsen I, et al
    PRO-C3-Levels in Patients with HIV/HCV-Co-Infection Reflect Fibrosis Stage and Degree of Portal Hypertension.
    PLoS One. 2014;9:e108544.
    PubMed     Text format     Abstract available


  204. CHRISTIANSEN KM, Mossner BK, Hansen JF, Jarnbjer EF, et al
    Liver Stiffness Measurement among Patients with Chronic Hepatitis B and C: Results from a 5-Year Prospective Study.
    PLoS One. 2014;9:e111912.
    PubMed     Text format     Abstract available


  205. HONG MZ, Zhang RM, Chen GL, Huang WQ, et al
    Liver stiffness measurement-based scoring system for significant inflammation related to chronic hepatitis B.
    PLoS One. 2014;9:e111641.
    PubMed     Text format     Abstract available


  206. ZHU X, Zhang J, Fan W, Gong Y, et al
    MAPKAP1 rs10118570 Polymorphism Is Associated with Anti-Infection and Anti-Hepatic Fibrogenesis in Schistosomiasis Japonica.
    PLoS One. 2014;9:e105995.
    PubMed     Text format     Abstract available


  207. CHEN J, Xu X, Wu J, Ling Q, et al
    The stratifying value of hangzhou criteria in liver transplantation for hepatocellular carcinoma.
    PLoS One. 2014;9:e93128.
    PubMed     Text format     Abstract available


  208. DVORAK K, Stritesky J, Petrtyl J, Vitek L, et al
    Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice - an exploratory case-control study.
    PLoS One. 2014;9:e111551.
    PubMed     Text format     Abstract available


  209. COSGROVE C, Berger CT, Kroy DC, Cheney PC, et al
    Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.
    PLoS One. 2014;9:e105950.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: